Literature DB >> 32010584

Type 2 diabetes mellitus does not increase the risk of lung cancer among never-smokers: a nationwide cohort study.

Hyung Jun Park1,2,3, Hee-Kyung Joh2,4,5, Seulggie Choi5, Sang Min Park5,6.   

Abstract

Previous studies have reported higher incidences of lung cancer among smokers diagnosed with diabetes than those without. Accordingly, this study investigated whether type 2 diabetes mellitus (T2DM) diagnosis alone can be associated with increased lung cancer incidences among never-smokers in the Korean population. Newly diagnosed never-smoking T2DM patients were identified from the nationwide longitudinal cohort of health examination data of South Korea (2002-2013). Cox proportional hazards regression model was employed to estimate the hazard ratios (HRs) and 95% confidence interval (CI) of lung cancer in the T2DM patient and abnormal fasting blood sugar (FBS) groups. T2DM (HR =0.91, 95% CI: 0.71 to 1.17) and abnormal FBS level are no significant association with lung cancer incidence based on the given HR. T2DM does not increase the risk of lung cancer among never-smokers. A large cohort study affirms minimal impact of T2DM on lung cancer development in the never-smoking Korean population. 2019 Translational Lung Cancer Research. All rights reserved.

Entities:  

Keywords:  Lung cancer; longitudinal study; type 2 diabetes mellitus cohort analysis (T2DM cohort analysis)

Year:  2019        PMID: 32010584      PMCID: PMC6976353          DOI: 10.21037/tlcr.2019.11.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  8 in total

1.  Cancer: diabetes therapy and lung cancer.

Authors:  Iley Ozerlat
Journal:  Nat Rev Endocrinol       Date:  2012-06-12       Impact factor: 43.330

Review 2.  Lung cancer in never smokers: disease characteristics and risk factors.

Authors:  Athanasios G Pallis; Konstantinos N Syrigos
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-04       Impact factor: 6.312

3.  Diabetes and the risk of lung cancer.

Authors:  Gillian C Hall; C Michael Roberts; Magdy Boulis; Jingping Mo; Kenneth D MacRae
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

Review 4.  Lung cancer in never smokers: a review.

Authors:  Janakiraman Subramanian; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  Metformin and lung cancer risk in patients with type 2 diabetes mellitus.

Authors:  Chin-Hsiao Tseng
Journal:  Oncotarget       Date:  2017-06-20

7.  Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai.

Authors:  Wan-Shui Yang; Yang Yang; Gong Yang; Wong-Ho Chow; Hong-Lan Li; Yu-Tang Gao; Bu-Tian Ji; Nat Rothman; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

8.  Lung cancer in never smokers in the UK Million Women Study.

Authors:  Kirstin Pirie; Richard Peto; Jane Green; Gillian K Reeves; Valerie Beral
Journal:  Int J Cancer       Date:  2016-03-31       Impact factor: 7.396

  8 in total
  3 in total

1.  Metabolic syndrome and the incidence of lung cancer: a meta-analysis of cohort studies.

Authors:  Li Qiao; Deliang Ma; Hui Lv; Ding Shi; Min Fei; Yu Chen; Fei Xie; Zhuoyan Wang; Ying Wang; Wanhua Liang; Peiying Hu
Journal:  Diabetol Metab Syndr       Date:  2020-10-28       Impact factor: 3.320

2.  Assessing the association of diabetes with lung cancer risk.

Authors:  Amanda Leiter; Antonios Charokopos; Stacyann Bailey; Emily J Gallagher; Fred R Hirsch; Derek LeRoith; Juan P Wisnivesky
Journal:  Transl Lung Cancer Res       Date:  2021-11

Review 3.  Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses.

Authors:  Pedro Barrios-Bernal; Zyanya Lucia Zatarain-Barrón; Norma Hernández-Pedro; Mario Orozco-Morales; Alejandra Olivera-Ramírez; Federico Ávila-Moreno; Ana Laura Colín-González; Andrés F Cardona; Rafael Rosell; Oscar Arrieta
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.